Skip to content
Screener

Quest Diagnostics DGX Equity Method Income

Equity Method Income at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
-$6.2M-265%
Opko Health logo
Opko HealthOPK
$0
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-$900K-400%

Other financials

Income statement

See full
Revenue$3.0B+10.2%
Gross profit$1.0B+8.9%
Operating income$459.0M+4.8%
Net income$320.0M+13.5%
EPS (diluted)$2.84+15.0%

Balance sheet

See full
Cash & equivalents$626.0M+96.2%
Total debt$6.4B0.0%
Total equity$7.5B+4.0%
Total assets$16.9B+6.1%

Cash flow

See full
Operating cash flow$597.0M+9.7%
CapEx$138.0M+27.8%
Free cash flow$459.0M+5.3%

Valuation

See full
Market cap$26.03B+34.6%
Enterprise value$31.79B+25.1%
P/E24.5×+4.1×
P/S2.3×+0.4×

Profitability

See full
Gross margin33.1%+0.1pp
Operating margin14.1%+0.1pp
Net margin9.2%+0.2pp
FCF margin11.7%0.0pp

Returns & leverage

See full
Return on equity14.4%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001022079-26-000070
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total non-operating expense, net(47)(54)(112)(124)
Income before income taxes and equity in earnings of equity method investees412384746660
Income tax expense(88)(97)(162)(156)
Equity in earnings of equity method investees, net of taxes1091427
Net income334296598531
Less: Net income attributable to noncontrolling interests14142629
Net income attributable to Quest Diagnostics$320$282$572$502
Earnings per share attributable to Quest Diagnostics’ common stockholders:

Cover / Front Matter

FAQ

What is Quest Diagnostics's equity method income?
Quest Diagnostics (DGX) reported equity method income of $10M in Q2 2026.
How has Quest Diagnostics's equity method income changed year-over-year?
Quest Diagnostics's equity method income increased by 11.1% year-over-year, from $9M to $10M.
What is the long-term trend for Quest Diagnostics's equity method income?
Over 4 years (2021 to 2025), Quest Diagnostics's equity method income has grown at a -14.3% compound annual growth rate (CAGR), from $78M to $42M.
What does equity method income mean?
The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.

Ask your AI about Quest Diagnostics's equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude